Sorry, you need to enable JavaScript to visit this website.

Greenstone LLC Announces Introduction of EXEMESTANE Tablets — Its Latest Generic Pharmaceutical Product

PEAPACK, N.J., May, 2011 — Greenstone LLC, the generic pharmaceutical subsidiary of Pfizer Inc., is pleased to announce the introduction of EXEMESTANE tablets to its ever-expanding generic pharmaceutical product line.

EXEMESTANE is the authorized generic of, and thereby fully substitutable for, Aromasin®. This new generic product from Greenstone is being offered in 25 mg tablets, available in bottles of 30 tablets.

EXEMESTANE, which complements the consistently growing line of products from Greenstone, is supported by a company heritage of commitment to quality, reliable manufacturing, and customer-focused attention.

Aromasin® is a registered trademark of Pfizer Inc.